MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1183/13993003.01552-2021

Медицинская библиотека · The European respiratory journal · 2022

Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline era.

Zelt Jason G E, Sugarman Jordan, Weatherald Jason, Partridge Arun C R, Liang Jiaming Calvin, Swiston John, Brunner Nathan, Chandy George, Stewart Duncan J, Contreras-Dominguez Vladimir, Thakrar Mitesh, Helmersen Doug, Varughese Rhea, Hirani Naushad, Umar Fraz, Dunne Rosemary, Doyle-Cox Caroyln, Foxall Julia, Mielniczuk Lisa

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The evolution in pulmonary arterial hypertension (PAH) management has been summarised in three iterations of the European Society of Cardiology/European Respiratory Society (ESC/ERS) guidelines. No study has assessed whether changes in management, as reflected in the changing guidelines, has translated to improved long-term survival in PAH.

METHODS

We performed a mixed retrospective/prospective analysis of treatment-naïve, incident PAH patients (n=392) diagnosed at three major centres in Canada from 2009 to 2021. Patients were divided into two groups based on their diagnosis date and in accordance with the 2009 and 2015 ESC/ERS guideline iterations. Overall survival was assessed based on date of diagnosis and initial treatment strategy (i.e. monotherapy versus combination therapy).

RESULTS

There was a shift towards more aggressive upfront management with combination therapy in Canada after the publication of the 2015 ESC/ERS guidelines (10.4% and 30.8% in patients from 2009 to 2015 and 36.0% and 57.4% in patients diagnosed after 2015 for baseline and 2-year follow-up, respectively). A key factor associated with combination therapy after 2015 was higher pulmonary vascular resistance (p=0.009). The 1-, 3- and 5-year survival rates in Canada were 89.2%, 75.6% and 56.0%, respectively. Despite changes in management, there was no improvement in long-term survival before and after publication of the 2015 ESC/ERS guidelines (p=0.53).

CONCLUSIONS

There was an increase in the use of initial and sequential combination therapy in Canada after publication of the 2015 ESC/ERS guidelines, which was not associated with improved long-term survival. These data highlight the continued difficulties of managing this aggressive pulmonary disease in an era without a cure.

Для цитирования: Zelt Jason G E, Sugarman Jordan, Weatherald Jason, Partridge Arun C R, Liang Jiaming Calvin, Swiston John, Brunner Nathan, Chandy George, Stewart Duncan J, Contreras-Dominguez Vladimir, Thakrar Mitesh, Helmersen Doug, Varughese Rhea, Hirani Naushad, Umar Fraz, Dunne Rosemary, Doyle-Cox Caroyln, Foxall Julia, Mielniczuk Lisa. Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline era.. The European respiratory journal. 2022. DOI: 10.1183/13993003.01552-2021.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.